Amgen Inc. v. F. Hoffmann-LaRoche LTD et al, No. 1:2005cv12237 - Document 985 (D. Mass. 2007)

Court Description: DECLARATION re 983 Opposition to Motion,, OF WILLIAM G. GAEDE, III IN SUPPORT OF AMGEN'S OPPOSITION TO DEFENDANTS' MOTION IN LIMINE TO PRECLUDE AMGEN FROM PRESENTING EVIDENCE REGARDING (1) A 1993 SETTLEMENT AGREEMENT BETWEEN AMGEN AND GENETICS INSTITUTE AND (2) A 1989 DECISION THAT GENETICS INSTITUTE USED CELLS THAT INFRINGED THE '008 PATENT by Amgen Inc.. (Attachments: # 1 Exhibit 1# 2 Exhibit 2)(Gottfried, Michael)

Download PDF
Amgen Inc. v. F. Hoffmann-LaRoche LTD et al Case 1:05-cv-12237-WGY Doc. 985 Document 985 Filed 09/04/2007 Page 1 of 3 UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS AMGEN INC., Plaintiff, v. F. HOFFMANN-LA ROCHE LTD, a Swiss Company, ROCHE DIAGNOSTICS GMBH, a German Company, and HOFFMANN LA ROCHE INC., a New Jersey Corporation, Defendants. ) ) ) ) ) ) ) ) ) ) ) ) ) ) Civil Action No.: 1:05-CV-12237 WGY DECLARATION OF WILLIAM G. GAEDE, III IN SUPPORT OF PLAINTIFF AMGEN INC. S OPPOSITION TO DEFENDANTS MOTION IN LIMINE TO PRECLUDE AMGEN FROM PRESENTING EVIDENCE REGARDING (1) A 1993 SETTLEMENT AGREEMENT BETWEEN AMGEN AND GENETICS INSTITUTE AND (2) A 1989 DECISION THAT GENETICS INSTITUTE USED CELLS THAT INFRINGED THE 008 PATENT. I, William G. Gaede, III, declare as follows: 1. I am a partner with McDermott Will & Emery LLP and counsel for Amgen Inc. in the above-captioned matter. 2. I am submitting this declaration in support of Plaintiff Amgen Inc. s Opposition to Defendants Motion In Limine to preclude Amgen from presenting evidence regarding (1) a 1993 settlement agreement between Amgen and Genetics Institute and (2) a 1989 decision that Genetics Institute used cells that infringed the 008 Patent. 3. I have knowledge of the following, and if called as a witness, could and would testify competently to the contents herein. 4. Attached as Exhibit 1 is a true and correct copy of a F. Hoffman-La Roche Ltd press release dated June 27, 2002. MPK 131731-1.041925.0023 1 GAEDE DECL. RE AMGEN S M/LIMINE RE BPAI DECISION CIVIL ACTION NO. 1:05-CV-12237 WGY Dockets.Justia.com Case 1:05-cv-12237-WGY 5. Document 985 Filed 09/04/2007 Page 2 of 3 Attached as Exhibit 2 is a true and correct copy of a letter from the chairman contained in F. Hoffman-La Roche Ltd s 2002 annual report. This letter can be obtained at: http://www.roche.com/pages/downloads/investor/pdf/reports/gb02/e02.pdf I declare, under penalty of perjury, under the laws of the United States, that the foregoing is true and correct and that this Declaration was completed at Palo Alto, California this 3rd day of September 2007. /s/William G. Gaede, III William G. Gaede, III MPK 131731-1.041925.0023 2 GAEDE DECL. RE AMGEN S M/LIMINE RE BPAI DECISION CIVIL ACTION NO. 1:05-CV-12237 WGY Case 1:05-cv-12237-WGY Document 985 Filed 09/04/2007 Page 3 of 3 CERTIFICATE OF SERVICE I hereby certify that this document filed through the Electronic Case Filing (ECF) system will be sent electronically to the registered participants as identified on the Notice of Electronic Filing (NEF) and paper copies will be sent to those indicated as non registered participants on the above date. /s/ Michael R. Gottfried Michael R. Gottfried MPK 131731-1.041925.0023 1 PROOF OF SERVICE CIVIL ACTION NO. 1:05-CV-12237 WGY

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.